"Real-Life" comparison of pegylated-interferon 2a versus 2b combination therapy of chronic hepatitis C virus.

Hepatology (Baltimore, Md.)

Volumn 53, Issue 4, 2011, Pages

  Zur Wiesch, Julian Schulze ^a   Pudelski, Neele ^a   Hoepner, Lena ^a   Supplieth, Michael ^a   Buggisch, Peter ^a   Lohse, Ansgar W ^a   Lüth, Stefan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; ALPHA2B INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADOLESCENT; ADULT; AGED; FEMALE; HEPATITIS C; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NOTE; RANDOMIZED CONTROLLED TRIAL (TOPIC); VIROLOGY;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RIBAVIRIN;

EID: 79958745507     PISSN: None     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24233     Document Type: Note

References (0)